2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

被引:202
作者
Tsubakihara, Yoshiharu [1 ]
Nishi, Shinichi [2 ]
Akiba, Takashi [4 ]
Hirakata, Hideki [12 ]
Iseki, Kunitoshi [13 ]
Kubota, Minoru [9 ]
Kuriyama, Satoru [8 ]
Komatsu, Yasuhiro [7 ]
Suzuki, Masashi [3 ]
Nakai, Shigeru [14 ]
Hattori, Motoshi [5 ]
Babazono, Tetsuya [6 ]
Hiramatsu, Makoto [15 ]
Yamamoto, Hiroyasu [10 ]
Bessho, Masami [16 ]
Akizawa, Tadao [11 ]
机构
[1] Osaka Gen Med Ctr, Dept Kidney Dis & Hypertens, Sumiyoshi Ku, Osaka 5588558, Japan
[2] Niigata Univ Med & Dent Hosp, Blood Purificat Ctr, Niigata, Japan
[3] Shinrakuen Hosp, Kidney Ctr, Niigata, Japan
[4] Tokyo Womens Med Univ, Kidney Dis Gen Med Ctr, Dept Blood Purificat, Tokyo, Japan
[5] Tokyo Womens Med Univ, Dept Pediat Nephrol, Kidney Ctr, Tokyo, Japan
[6] Tokyo Womens Med Univ, Dept Med, Ctr Diabet, Tokyo, Japan
[7] St Lukes Int Hosp, Kidney Ctr, Tokyo, Japan
[8] Saiseikai Cent Hosp, Div Nephrol, Tokyo, Japan
[9] Oji Hosp, Tokyo, Japan
[10] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens, Tokyo, Japan
[11] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan
[12] Fukuoka Red Cross Hosp, Kidney Unit, Fukuoka, Japan
[13] Univ Ryukyus, Dialysis Unit, Okinawa, Japan
[14] Fujita Hlth Univ Coll, Div Clin Engn Technol, Aichi, Japan
[15] Okayama Saiseikai Gen Hosp, Dept Nephrol, Okayama, Japan
[16] Saitama Med Sch, Dept Hematol, Saitama, Japan
关键词
Chronic dialysis; Erythropoiesis stimulating agent; Guidelines; Hemoglobin; Non-dialysis Chronic kidney disease; Pediatric chronic kidney disease; Quality of life; Renal anemia; Serum erythropoietin concentration; RECOMBINANT-HUMAN-ERYTHROPOIETIN; RED-CELL APLASIA; INTRAVENOUS IRON THERAPY; QUALITY-OF-LIFE; HEMODIALYSIS-PATIENTS; DARBEPOETIN-ALPHA; SUBCUTANEOUS ERYTHROPOIETIN; SERUM ERYTHROPOIETIN; PRACTICE PATTERNS; EPOETIN-ALPHA;
D O I
10.1111/j.1744-9987.2010.00836.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Japanese Society for Dialysis Therapy (JSDT) guideline committee, chaired by Dr Y. Tsubakihara, presents the Japanese guidelines entitled "Guidelines for Renal Anemia in Chronic Kidney Disease." These guidelines replace the "2004 JSDT Guidelines for Renal Anemia in Chronic Hemodialysis Patients," and contain new, additional guidelines for peritoneal dialysis (PD), non-dialysis (ND), and pediatric chronic kidney disease (CKD) patients.
引用
收藏
页码:240 / 275
页数:36
相关论文
共 191 条
[1]  
*ABB JAP CO LTD, 2007, SUST REL PREP FER
[2]  
ABELS RI, 1992, SEMIN ONCOL, V19, P29
[3]   A Randomized controlled trial of oral versus intravenous iron in chronic kidney disease [J].
Agarwal, Rajiv ;
Rizkala, Adel R. ;
Bastani, Bahar ;
Kaskas, Marwan O. ;
Leehey, David J. ;
Besarab, Anatole .
AMERICAN JOURNAL OF NEPHROLOGY, 2006, 26 (05) :445-454
[4]  
AKIBA T, 2001, MED PHARM, V46, P47
[5]  
AKIBA T, 1995, TODAYS PHARM INFORM, V12, P87
[6]  
Akizawa T, 2007, J AM SOC NEPHROL, V18, p762A
[7]   Darbepoetin alfa effectively maintains hemoglobin concentrations at extended dose intervals relative to intravenous rHuEPO in Japanese dialysis patients [J].
Akizawa, Tadao ;
Koshikawa, Shozo ;
Iwasaki, Manabu .
THERAPEUTIC APHERESIS AND DIALYSIS, 2007, 11 (03) :220-226
[8]  
ALI M, 1980, JAMA-J AM MED ASSOC, V244, P343
[9]   IRON-DEFICIENCY IN MAINTENANCE HEMODIALYSIS-PATIENTS - ASSESSMENT OF DIAGNOSIS CRITERIA AND OF 3 DIFFERENT IRON TREATMENTS [J].
ALLEGRA, V ;
MENGOZZI, G ;
VASILE, A .
NEPHRON, 1991, 57 (02) :175-182
[10]  
ALMOND MK, 1994, NEPHROL DIAL TRANSPL, V9, P270